Litcius/Paper detail

Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)

Jolien F. van Nimwegen, Esther Mossel, Greetje S. van Zuiden, Robin F. Wijnsma, Konstantina Delli, Alja J. Stel, Bert van der Vegt, Erlin A. Haacke, Lisette Olie, Leonoor I. Los, Gwenny M. Verstappen, Sarah Pringle, Fred K. L. Spijkervet, Frans G. M. Kroese, Arjan Vissink, Suzanne Arends, Hendrika Bootsma

2020The Lancet Rheumatology88 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAbataceptPlaceboRheumatismInternal medicineRheumatologyAdverse effectRandomized controlled trialPhysical therapySurgeryRituximabPathologyAlternative medicineLymphomaSalivary Gland Disorders and FunctionsRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus Research